| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.016 | 0.8 |